Celcuity Inc.
NASDAQ:CELC
Overview | Financials
Company Name | Celcuity Inc. |
Symbol | CELC |
Currency | USD |
Price | 12.7 |
Market Cap | 471,545,920 |
Dividend Yield | 0% |
52-week-range | 11.51 - 22.188 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Brian F. Sullivan |
Website | https://www.celcuity.com |
An error occurred while fetching data.
About Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD